期刊文献+

JNK/SAPK和p38MAPK途径在CCL21/CCR7趋化类风湿关节炎患者外周血淋巴细胞过程中的作用 被引量:5

The roles of JNK/SAPK and p38MAPK pathways in CCL21/CCR7-mediated peripheral blood lymphocyte chemotaxis in the patients with rheumatoid arthritis
原文传递
导出
摘要 目的通过对JNK/SAPK和p38MAPK信号转导通路在外周血淋巴细胞迁移过程中作用的研究,探讨类风湿关节炎(RA)的发病机制。方法选择20例RA患者,均符合1987年美国风湿病学会推荐的RA分类标准;正常对照20名,为健康体检者。分离出外周血淋巴细胞,应用Western-blot方法检测JNK/SAPK和p38MAPK的表达。结果 RA患者外周血淋巴细胞内p-JNK和p-p38MAPK的表达均高于正常对照组(P<0.05);加入CCL21作用后,正常对照者和RA患者的淋巴细胞表达p-JNK和p-p38MAPK均比CCL21作用前明显增加,且RA患者与正常对照者相比增加更多;而加入抗CCR7抗体后,p-JNK和p-p38MAPK的表达均明显下降(P<0.01)。结论 CCL21/CCR7作为胞外信号分子能够通过激活外周血淋巴细胞的JNK和p38MAPK通路,介导淋巴细胞的迁移,在RA患者淋巴细胞向炎症部位聚集的过程中发挥重要作用,也为控制RA病情的发生发展开辟了新的思路。 To explore the pathogenesis of rheumatoid arthritis(RA),we investigated the roles of JNK/SAPK and p38MAPK pathways on CCL21/CCR7-mediated peripheral blood lymphocyte chemotaxis in RA patients.Total of 20 RA patients,accorded with the classificatory standard recommended by ACR in 1987,were selected,while 20 healthy individuals were recruited as normal controls.Western blot assays showed that the expressions of JNK and p38MAPK in peripheral blood lymphocytes from RA patients were higher than that from normal controls.Moreover,after adding CCL21,we found the expressions of JNK and p38MAPK increased greatly and the expressions in RA patients increased more highly than that in normal controls.While after anti-CCR7 antibody was added to the samples,the expressions of JNK and p38MAPK decreased significantly.As one of important extracellular signal molecules,CCL21 interacts with CCR7 and mediates lymphocyte migration by activating JNK/SAPK and p38MAPK pathways,thus plays important roles on lymphocytes gathering to inflammatory sites in the patients with RA.
出处 《免疫学杂志》 CAS CSCD 北大核心 2011年第3期246-249,共4页 Immunological Journal
基金 国家自然科学基金资助项目(30801204)
关键词 类风湿关节炎 JNK/SAPK P38MAPK 淋巴细胞 信号转导 Rheumatoid arthritis JNK/SAPK p38MAPK Lymphocyte Signal transduction
  • 相关文献

参考文献10

  • 1古沽若,陶怡.临床风湿病学教程[M].北京:人民卫生出版社,2009:110-121.
  • 2Szekanecz Z, Sz u cs G, Sz a nt o S, et al. Chemokines in rheumatic diseases[J]. Curr drug targets, 2006, 7(1): 91-102.
  • 3OndrouSkov a E, Slov a ckov a J, Pelkov a V, et al. Heavy metals induce phosphorylation of the Bcl-2 protein by Jun N-terminal kinase[J]. Biol Chem, 2009, 390(1): 49-58.
  • 4Shahrara S, Pickens SR, Dorfleutner A, et al. IL-17 induces monocyte migration in rheumatoid arthritis [J]. J Immunol, 2009, 182(6):3884-3891.
  • 5王越,杨洁,高燕,东莉洁,姚智.IL-6、IL-8上调卵巢癌细胞雄激素受体表达的作用分别依赖MAPK途径和Src活化[J].免疫学杂志,2008,24(4):424-429. 被引量:19
  • 6Berzat A, Hall A. Cellular responses to extracellular guidance cues[J]. EMBO J, 2010, 29(16): 2754-2745.
  • 7Cotton M, Claing A. G protein-coupled receptors stimulation and the control of cell migration[J]. Cell Signal, 2009, 21 (7): 1045-1053.
  • 8Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases [J]. Biochim Biophys Acta, 2010, 1802(4): 396-405.
  • 9Huang C, Rajfur Z, Borchers C, et al. JNK phosphorylates paxillin and regulates cell migration [J]. Nature, 2003, 424 (6945): 219-223.
  • 10Saika S, Okada Y, Miyamoto T. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium [J]. Invest Ophthalmol Vis Sei, 2004, 45(1): 100-109.

二级参考文献20

  • 1王越,杨洁,高燕,牛文彦,姚智.DHT、IL-6和IL-8对卵巢癌细胞体外增殖的作用[J].中华微生物学和免疫学杂志,2006,26(2):115-120. 被引量:6
  • 2王越,杨洁,高燕,牛文彦,姚智.卵巢癌细胞IL-6、IL-8及其受体表达的研究[J].免疫学杂志,2006,22(5):475-479. 被引量:16
  • 3Penson RT, Kronish K, Duan Z, et al. Cytokines IL-1beta,IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxe [JJ. Int J Gynecol Cancer, 2000, 10 (1): 33-41.
  • 4Duan Z, Feller A J, Penson RT, et al. Discovery of differentially expressed genes associated -with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype[J]. Clin Cancer Res, 1999, 5 (11): 3 445-3 453
  • 5Toutirais O, Chartier P, Dubois D, et al. Constitutive expression of TGF-beta, interleukin-6 and interleukin-8 by tumor cells as a major component of immune escape in human ovarian carcinoma[J]. Eur Cytokine Netw, 2003, 14 (4) : 246 - 255.
  • 6Wang PH, Chang C. Androgens and ovarian cancers[J]. Eur J Gynaecol Oncol, 2004, 25 (2) :157 - 163.
  • 7Abrahamsson G, Janson PO, Kullander S, Steroid release from two human epithelial ovarian tumors: evidence for an intrinsic production in vitro [ J]. Gynecol Oncol, 1997, 64 (1): 99-104.
  • 8Cardillo MR, Petrangeli E, Aliotta N, et al. Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study[J]. J Exp Clin Cancer Res, 1998, 17 (2): 231 - 237.
  • 9Helzlsouer KJ, Alberg A J, Gordon GB, et al. Serum gonadotropins and steroid hormones and the development of ovarian eancer[JJ. JAMA, 1995, 274 (24) : 1 926- 1 930.
  • 10Schildkraut JM, Schwingl PJ, Bastos E, et al. Epithelial ovarian cancer risk among women with polycystic ovary syndrome[J]. Obstet Gynecol, 1996, 88 (4 Pt 1): 554- 559.

共引文献18

同被引文献67

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部